vs
Side-by-side financial comparison of Forestar Group Inc. (FOR) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $170.6M, roughly 1.6× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs 5.6%, a 71.5% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs 9.0%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $-157.1M).
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
FOR vs PTGX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $273.0M | $170.6M |
| Net Profit | $15.4M | $131.7M |
| Gross Margin | 20.1% | — |
| Operating Margin | 7.6% | 74.3% |
| Net Margin | 5.6% | 77.2% |
| Revenue YoY | 9.0% | 184.4% |
| Net Profit YoY | -6.7% | 381.7% |
| EPS (diluted) | $0.30 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $273.0M | — | ||
| Q3 25 | $670.5M | — | ||
| Q2 25 | $390.5M | — | ||
| Q1 25 | $351.0M | — | ||
| Q4 24 | $250.4M | $170.6M | ||
| Q3 24 | $551.3M | — | ||
| Q2 24 | $318.4M | — | ||
| Q1 24 | $333.8M | $255.0M |
| Q4 25 | $15.4M | — | ||
| Q3 25 | $86.9M | — | ||
| Q2 25 | $32.9M | — | ||
| Q1 25 | $31.6M | — | ||
| Q4 24 | $16.5M | $131.7M | ||
| Q3 24 | $81.5M | — | ||
| Q2 24 | $38.7M | — | ||
| Q1 24 | $45.0M | $207.3M |
| Q4 25 | 20.1% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 22.6% | — | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 24.9% | — |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | 11.6% | — | ||
| Q4 24 | 8.7% | 74.3% | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 16.2% | — | ||
| Q1 24 | 17.6% | 80.9% |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 6.6% | 77.2% | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 12.2% | — | ||
| Q1 24 | 13.5% | 81.3% |
| Q4 25 | $0.30 | — | ||
| Q3 25 | $1.70 | — | ||
| Q2 25 | $0.65 | — | ||
| Q1 25 | $0.62 | — | ||
| Q4 24 | $0.32 | $2.01 | ||
| Q3 24 | $1.59 | — | ||
| Q2 24 | $0.76 | — | ||
| Q1 24 | $0.89 | $3.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $211.7M | $418.9M |
| Total DebtLower is stronger | $793.2M | — |
| Stockholders' EquityBook value | $1.8B | $675.3M |
| Total Assets | $3.2B | $744.7M |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $211.7M | — | ||
| Q3 25 | $379.2M | — | ||
| Q2 25 | $189.2M | — | ||
| Q1 25 | $174.3M | — | ||
| Q4 24 | $132.0M | $418.9M | ||
| Q3 24 | $481.2M | — | ||
| Q2 24 | $359.2M | — | ||
| Q1 24 | $416.2M | $322.6M |
| Q4 25 | $793.2M | — | ||
| Q3 25 | $802.7M | — | ||
| Q2 25 | $872.8M | — | ||
| Q1 25 | $872.5M | — | ||
| Q4 24 | $806.8M | — | ||
| Q3 24 | $706.4M | — | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | — |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | $675.3M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | $560.4M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.0B | $744.7M | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.6B | $629.3M |
| Q4 25 | 0.44× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.50× | — | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-157.0M | $184.2M |
| Free Cash FlowOCF − Capex | $-157.1M | $182.8M |
| FCF MarginFCF / Revenue | -57.5% | 107.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.8% |
| Cash ConversionOCF / Net Profit | -10.19× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $93.0M | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-157.0M | — | ||
| Q3 25 | $256.3M | — | ||
| Q2 25 | $15.8M | — | ||
| Q1 25 | $-19.8M | — | ||
| Q4 24 | $-450.0M | $184.2M | ||
| Q3 24 | $119.2M | — | ||
| Q2 24 | $-61.7M | — | ||
| Q1 24 | $-59.2M | $-27.4M |
| Q4 25 | $-157.1M | — | ||
| Q3 25 | $255.6M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $-20.5M | — | ||
| Q4 24 | — | $182.8M | ||
| Q3 24 | $118.4M | — | ||
| Q2 24 | $-62.3M | — | ||
| Q1 24 | $-59.8M | $-27.7M |
| Q4 25 | -57.5% | — | ||
| Q3 25 | 38.1% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | — | 107.1% | ||
| Q3 24 | 21.5% | — | ||
| Q2 24 | -19.6% | — | ||
| Q1 24 | -17.9% | -10.9% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | 0.1% |
| Q4 25 | -10.19× | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | -0.63× | — | ||
| Q4 24 | -27.27× | 1.40× | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
PTGX
Segment breakdown not available.
